FindTrial
Sign In

Treatment of BV With First Deqularum and Then Direkt After Clindamycin

Treatment of BV With First Deqularum and Then Direkt After With Vaginal Clindamycin Cream.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04067531
Acronym
BV
Enrollment
50
Registered
2019-08-26
Start date
2020-08-01
Completion date
2021-12-01
Last updated
2020-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Bacterial

Brief summary

Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.

Detailed description

The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria. Cure rate will be followed up after 1 month and then after 6 month

Interventions

DRUGtreatment of BV with first Deqularum and then direkt after with vaginal clindamycin

All patients will get the same treatment

Sponsors

Skaraborg Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* healthy women with BV

Exclusion criteria

* women treated with antibiotics within 1 month

Design outcomes

Primary

MeasureTime frameDescription
cure of BV6 monthcure rate of BV

Countries

Sweden

Contacts

Primary ContactP-G Larsson
p-g.larsson@vgregion.se+46500431000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026